Rite Aid Corp (RAD)
The Company is a Delaware corporation and through its wholly-owned subsidiaries, operates retail drugstores in the United States of America.
Recs
Aging population, prescription drugs and strong population growth for New Hampshire outlets
Recs
why not?
Recs
your local last minute stop from home,they already grew past other drugstores and for perscription they are holdin there own but be carefull for walmart,they are doing the expeirament with cheaper cost but we can see how that works out for florida first?
Recs
Cheap, cheap, cheap. Can't go anywhere but up (unless it goes out of business).
Recs
It may take a year or two to recover from the cost of buying out Brooks and the price will sneak up slowly but $2 for a stock that splits at $20+ is a bargin.
Recs
True, Rite Aid has their bag of problems, however at <3 P/E the stock is extremely cheap. Their brand name alone is worth more than that. Plus, at $2B market cap they are an easy acquisition target by Walgreen or CVS, which seem overvalued and might be tempted to cash in their high stock prices by sweeping up competition.
Recs
This is your lottery ticket.
Recs
attractive to seniors and 50 age group to purchase products here. Neighborhood drugstore, accessibility to inner city population.
Recs
Heavily leveraged #3 drugstore chain, trading at a low multiple to potential earnings 1-2 years down the road, will be a homerun if they aren't choked by a mountain of debt. High interest rates would do them in, but 2/3 of income coming from prescription drugs should protect them from recessionary slowdown so they are a play on recession and the low interest rates that would probably go with it.
Recs
Turn around situation.
Recs
Cheap compared to other in the group.
Recs
Ekerd now dovetailed in and operating efficiencies should become more apparent
Recs
growing market share.
Recs
Investing doesn't get better than this. RAD is going back to the teens. Don't worry about CVS and Walgreens... they might be bigger, but RAD is much much cheaper and quickly gathering a respectable market share. There is going to be a lot of growth this Flu season and RAD is going to lead the return in it's sector.
Recs
A speculative, turnaround drugstore play trading very close to all-time lows of $1.35/share as integration of Brooks/Eckerd along with promotional spending continues to generate losses. Longer term, over 5,000 locations should capitalize on convenience as consumers look for local solutions due to high gas prices.
Recs
Once Rite Aid gets behind it the "jitters" of the Brooks Eckard acquisition, I believe it will begin to stabilize and quell fears in the eyes of investors.
Recs
Growing share should equate to growing earnings...
Recs
aquiring brooks drugs, beaten 52 wk high and held on to the gain for over 4 days trading. same store sales up +2.4 or better
Recs
Recs
This is a great stock, rapid growth.
This should be in $50 range.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 185 1 2 3 4 5 6 7 8 9 10 Next »